1965
DOI: 10.1038/207308a0
|View full text |Cite
|
Sign up to set email alerts
|

Use of Inhibitors in Cholinesterase Histochemistry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1966
1966
1973
1973

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…A number of points may be raised which indicate the need for further work from the standpoints of physiology and toxicology. The histochemical tests employed here do not distinguish between AChE and ChE; this requires the use of selective inhibitors, as discussed for example by Pearse ( 1960), and Diegenbach (1965). While the use of whole mounts ensures a minimum loss of enzymes in processing, it does not allow precise localizations of enzymes to be made, as is possible with either thin sections under light microscopy or with the electron microscope.…”
Section: Discussionmentioning
confidence: 99%
“…A number of points may be raised which indicate the need for further work from the standpoints of physiology and toxicology. The histochemical tests employed here do not distinguish between AChE and ChE; this requires the use of selective inhibitors, as discussed for example by Pearse ( 1960), and Diegenbach (1965). While the use of whole mounts ensures a minimum loss of enzymes in processing, it does not allow precise localizations of enzymes to be made, as is possible with either thin sections under light microscopy or with the electron microscope.…”
Section: Discussionmentioning
confidence: 99%
“…After washing the sections, the sites of enzyme activity were visualized by using fresh, dilute ammonium sulphide. Sections were air dried at 37°C and then mounted in Canada Balsam in tctraehlorethylene [371 The differential inhibitors used as a check on the types of cholinesterases present were 1 x 10 5 M physostigmine for both enzymes [9], 1x10 5 M 1,5-bis (4-trimethylammonium phenyl) penlan-3-one di-iodide (Wellcome Laboratories 62C47) to in hibit acetylcholinesterase (15), and 2x10 5 M N, N-di-isopropylphosphorodiamidic fluoride (Mipafox) to inhibit butyrylcholinesterase [211. To prevent artifacts due to dissociation of the enzyme-inhibitor complex all inhibitions were carried out by coincubation.…”
mentioning
confidence: 99%